☆ 4.7 Article

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial

EBIOMEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

UK guideline for the use of HIV post-exposure prophylaxis 2021

Fiona Cresswell et al.

Summary: This article presents the updated guidelines from the British Association for Sexual Health and HIV (BASHH) on post-exposure prophylaxis (PEP) for HIV. The guidelines aim to provide evidence-based guidance on the best practices for providing, monitoring, and supporting PEP for the prevention of HIV transmission. The guidelines cover topics such as when to prescribe PEP, which antiretroviral agents to use, and how to manage PEP.

HIV MEDICINE (2022)

添加到收藏夹

Article Immunology

Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis

Jing Zhang et al.

Lancet HIV (2022)

添加到收藏夹

Article Multidisciplinary Sciences

The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans

Carolina Herrera et al.

Summary: The utility of non-human primates in evaluating antiretroviral drugs for HIV treatment and prevention is questionable due to pharmacological differences between humans and macaques. We developed an ex vivo model using tissue explants to identify differences in drug efficacy between the two species. Our results showed that high concentrations of tenofovir and maraviroc predicted anti-viral efficacy, with greater inhibitory potency observed in macaques compared to humans.

ISCIENCE (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue

Laura Else et al.

Summary: This study assessed the pharmacokinetic-pharmacodynamic profile of tenofovir and tenofovir alafenamide in foreskin tissue. The results showed that tenofovir alafenamide had greater potency against penile HIV transmission than tenofovir.

PHARMACEUTICS (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

The potential effect of pre-exposure prophylaxis (PrEP) roll-out on sexual-risk behaviour among adolescents and young people in East and southern Africa

Andrew Sentoogo Ssemata et al.

Summary: PrEP roll-out could potentially influence sexual risk behavior among adolescents and young people, leading to decreased condom use, increased sexual activities, and changes in HIV risk perception. It is important to include PrEP as part of a comprehensive package of HIV prevention strategies, along with measures to prevent other sexually transmitted infections and unwanted pregnancies.

AJAR-AFRICAN JOURNAL OF AIDS RESEARCH (2022)

添加到收藏夹

Article Immunology

Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data

Katia Giguere et al.

Summary: This study examines the progress and gaps in reaching the UNAIDS 2020 target of 90% knowledge of HIV status, and the efficiency of HIV testing services in sub-Saharan Africa using data from surveys and national HIV testing reports. Knowledge of HIV status has increased from 5.7% in 2000 to 84% in 2020, with disparities among gender and age groups. In order to achieve the next UNAIDS target of 95% diagnostic coverage by 2025, addressing disparities in knowledge of status is crucial.

LANCET HIV (2021)

添加到收藏夹

Article Infectious Diseases

Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP)

Carolina Herrera et al.

Summary: In this study, the combination of raltegravir and lamivudine showed better efficacy in preventing HIV infection compared to raltegravir alone, particularly providing higher protection in rectal and vaginal tissues. Drug concentrations varied in different body compartments, with concentrations persisting in rectal and vaginal tissues after discontinuation. These results suggest that raltegravir and lamivudine may be effective agents for PrEP.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

添加到收藏夹

Article Immunology

Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/tenofovir alafenamide vs. emtricitabine/tenofovir disoproxil fumarate

Jenna L. Yager et al.

Summary: This study found through two randomized trials that F/TAF produced 6.7 to 7.3-fold higher TFV-DP concentrations in PBMC compared to F/TDF across different levels of adherence. This suggests that F/TAF has increased potency and pharmacologic forgiveness in the PBMC compartment.

AIDS (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

HIV services in sub-Saharan Africa: the greatest gap is men

Morna Cornell et al.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

Andrea R. Thurman et al.

Summary: This study compared the pharmacokinetics and safety of F/TDF and F/TAF in HIV uninfected women, finding that F/TAF was safe and well-tolerated. Compared to F/TDF, F/TAF had higher TFV-DP concentrations in PBMCs and female genital tract tissues.

ECLINICALMEDICINE (2021)

添加到收藏夹

Article Immunology

HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study

Christian Laurent et al.

Summary: The study on HIV pre-exposure prophylaxis (PrEP) in men who have sex with men (MSM) in West Africa showed that PrEP could effectively prevent HIV infection without increasing risky sexual behaviors or other sexually transmitted infections. Urgent implementation of PrEP in West Africa is recommended, with special attention to retention in care and PrEP adherence to ensure its full prevention potential.

LANCET HIV (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial

S. Nash et al.

TRIALS (2020)

添加到收藏夹

Article Infectious Diseases

Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial

Julien Fonsart et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

添加到收藏夹

Article Immunology

Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results

Jose R. Arribas et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)

添加到收藏夹

Article Infectious Diseases

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues

Mackenzie L. Cottrell et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)

添加到收藏夹

Article Immunology

A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine

Mackenzie L. Cottrell et al.

JOURNAL OF INFECTIOUS DISEASES (2016)

添加到收藏夹

Article Medicine, General & Internal

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Paul E. Sax et al.

LANCET (2015)

添加到收藏夹

Article Medicine, General & Internal

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

J. -M. Molina et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Immunology

Single Dose Pharmacokinetics of Oral Tenofovir in Plasma, Peripheral Blood Mononuclear Cells, Colonic Tissue, and Vaginal Tissue

Nicolette A. Louissaint et al.

AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)

添加到收藏夹

Article Cell Biology

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

Peter L. Anderson et al.

SCIENCE TRANSLATIONAL MEDICINE (2012)

添加到收藏夹

Article Cell Biology

Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission

Kristine B. Patterson et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

添加到收藏夹

Article Immunology

HIV-1 infection of human penile explant tissue and protection by candidate microbicides

Lucia Fischetti et al.

AIDS (2009)

添加到收藏夹

Article Immunology

Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides

Patricia S. Fletcher et al.

AIDS (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.